Disclaimer

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions



DO YOU WISH TO CONTINUE AND ENTER THIS WEBSITE?

SJM-CV WEB-0718-0009

/content/bss/divisionalsites/livesites/reusable/cv-livesite/us/en/pages/home
30
CARDIOVASCULAR
hamburger
BACK
TactiCath
About

Experience innovative ablation technology

TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ is an innovative solution for the treatment of atrial fibrillation featuring advanced handle-shaft technology and full integration with Abbott’s EnSite Precision™ Cardiac Mapping System.

The TactiCath Contact Force Ablation Catheter, Sensor Enabled system and monitor.

TactiCath Contact Force Ablation Catheter, Sensor Enabled

Accurate

At the heart of the TactiCath Contact Force Ablation Catheter, Sensor Enabled is light interferometry technology. During bench testing, the TactiCath Contact Force Ablation Catheter, Sensor Enabled was highly accurate, with a mean accuracy of 0.3 grams.1

TactiCath Contact Force Ablation Catheter, SE closeups discussing particular catheter features.

Effortless handling2*

  • Advanced handle-shaft combination offers maneuverability, along with comfort and ease of use2
  • A variety of curve sizes accommodates size differences in patient anatomy
The bidirectional handle of the TactiCath Contact Force Ablation Catheter, SE.

                                                                                   

The unidirectional handle of the TactiCath Contact Force Ablation Catheter, SE.

Integrated3,4

  • Get novel insight into mapping and lesion marking through AutoMark feature advanced technology.
  • Increase procedural consistency through automated guidance of lesion marking via the AutoMark feature.3
Cardiac mapping image with the Metrics integration display of the TactiCath Contact Force Ablation Catheter, SE.
Metrics integration display of the TactiCath Contact Force Ablation Catheter, SE.
  • Verify ablation catheter stability and AutoMark placement with the AutoTrack feature, which automatically records the precise location of the tip during radio frequency energy application.2
  • Review and identify any potential gaps by viewing specific lesions from the display list.
Cardiac mapping display of the TactiCath Contact Force Ablation Catheter, SE automark placement.
  • Optimize your workflow with customizable CF display.
  • Map with precision via EnSite™ AutoMap module technology — designate the system to collect mapping points only if the CF is within a specified range.3,4
  • Uniquely integrate magnetic and impedance data.
  • Adapt to changing needs — introduce the TactiCath Contact Force Ablation Catheter, Sensor Enabled at any point during the procedure.3,4
Cardiac mapping display of the TactiCath Contact Force Ablation Catheter, SE automark placement.

*Effortless handling is based on how physicians scored catheter handling characteristics during an initial market release.

References

  1. Abbott. Data on File. Report 90430651
  2. Abbott. Data on File. Report 90349982.
  3. Abbott. Data on File. Report 90214738.
  4. Abbott. Data on File. Report 90253949.
Indications, Safety & Warnings

MAT-2102828 v1.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2021 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

YESNO
accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

YESNO
accessibility
© 2021 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

YESNO
accessibility

The following content is intended for Healthcare Professionals except for those in France. Some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.



Si vous êtes un professionnel de santé exerçant en France ou dans les territoires Français, veuillez visiter notre site en français.



Do you want to continue? 

YesNo